Notably, blood glucose monitoring data revealed that the GAD65 + KYN group effectively prevented the development of hyperglycaemia in 94% of mice for at least 6 weeks, compared to 88% in the GAD65 group. Here, GAD2 is linked to Hyperglycemia.